Weekly Full Operating Cycle

2026-08-09 Weekly Full Operating Cycle

Hold 17 RKLB, 11 ASTS and 6 MDA; add zero and sell zero; retain confirmed USD 7334.45 cash only through the Rocket Lab August 10 result.

2026-08-09Completed No Actionv1.3

Not investment advice. This is a delayed historical run record. Proposed or simulated actions are not current instructions. Confirmed execution appears only from linked ledger events.

Analysis

August 7 completed closes, MDA Q2, current full-universe SEC coverage, six new R1 readiness sprints, GSAT transaction freeze, 64-symbol decision coverage, MDA three-share-versus-zero analysis and six independent xhigh reviewer roles.

Decision result

Completed no-action decision under v1.3. Existing MDA exposure captures the strengthened operating thesis, while negative cash conversion, acquisition and dilution uncertainty, no entry margin and the imminent Rocket Lab result make zero incremental quantity superior for this short event window.

Execution boundary

The due 2026-08-07 USD 888 standing contribution was applied once; no broker trade, order, fill, fee, reserve position or other account fact changed.

Confirmed execution

Date	Action	Quantity	Average price	Net cash
2026-08-07	2026-08-07-deposit-weekly-888-001	N/A	N/A	$888.00

2026-08-07

Quantity: N/A
Average price: N/A
Net cash: $888.00

2026-08-07-deposit-weekly-888-001

Primary symbols

MDA / RKLB / ASTS / GILT / LEU / IREN / SEI

Publication

Public Safe No Action

Next trigger

Rocket Lab August 10 results; MDA price move beyond USD 32.85 or USD 36.32; MDA acquisition financing or cash-conversion evidence; another material issuer event; or a confirmed account change

Validation

Article 1 decision and data checks passed; npm run verify passed and generated 91 static pages; the local release candidate and pre-release production baseline returned HTTP 200 on key dashboard, run and MDA research pages with no document-level horizontal overflow at 390-pixel mobile and 1280-pixel desktop widths; sensitive-field review passed

Source files

Decision note: 2026-08-09-weekly-operating-cycle.md Run artifact: 2026-08-09-weekly-full-operating-cycle.yml Evidence packet: 2026-08-09-subagent-evidence-packet.yml

Notes

The latest confirmed mission-relevant deployment remains the August 6 MDA starter and the 45-day review date is September 20. A three-share MDA add was explicitly tested and rejected only for this event window; USD 34.60 remains a research ceiling rather than an order, and no executable limit exists.